BioArctic Neuroscience AB and Swenora Biotech AB have announced the formation of an exclusive agreement geared towards a new type of treatment for spinal cord injuries.
With the goal of improving “functional recovery and quality of life for patients with spinal cord injury”, Swenora has created peripheral nerve grafts. In combination with a growth factor, these grafts have assisted with spinal cord repair in rodents.
This repair is applied by using a biodegradable device that combines peripheral nerves and a growth factor. It is used during neurosurgery when injured tissue is replaced. We will be keeping an eye out for more news on this advancement as it bodes well for the many patients with spinal cord injuries.